Refine Search
(299)
(503)
(519)
(649)

Familial Amyloid Neuropathies - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Familial Amyloid Neuropathies - Pipeline Review, H1 2018’, provides an overview of the Familial Amyloid Neuropathies pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Hyperinsulinemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperinsulinemia - Pipeline Review, H1 2018’, provides an overview of the Hyperinsulinemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperinsulin...

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018’, provides an overview of the Retinitis Pigmentosa (Retinitis) pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2018’, provides an overview of the Vaginal Atrophy (Atrophic Vaginitis) pipeline landscape.

The report provides comprehensive information on the therape...

Graves Diseases - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Graves Diseases - Pipeline Review, H1 2018’, provides an overview of the Graves Diseases pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Graves Disease...

Presbyopia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Presbyopia - Pipeline Review, H1 2018’, provides an overview of the Presbyopia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Presbyopia, complete wit...

Hyperglycemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperglycemia - Pipeline Review, H1 2018’, provides an overview of the Hyperglycemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperglycemia, com...

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2018’, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) pipeline landscape.

The report provi...

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018’, provides an overview of the Hyperphosphatemia In Chronic Kidney Disease pipeline landscape.

The report provides comprehensive information ...

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2018’, provides an overview of the Ornithine-Transcarbamylase Deficiency pipeline landscape.

The report provides comprehensive information on the thera...

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H1 2018’, provides an overview of the Neurofibromatoses Type I (Von Recklinghausen’s Disease) pipeline landscape.

The report provides co...

Gaucher Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gaucher Disease - Pipeline Review, H1 2018’, provides an overview of the Gaucher Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gaucher Diseas...

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018’, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline landscape.

The report provides comprehensive info...

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2018’, provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) pipeline landscape.

The report provides comprehensiv...

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2018’, provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) pipeline landscape.

The report provides comprehe...